| Code | 2354D | ||||||||||
| MA number | 77/0269/19-S | ||||||||||
| Product Form: | cps dur 30x0,5 mg/0,4 mg (fľ.HDPE) | ||||||||||
| MA Status: | R - Valid Marketing Authorisation | ||||||||||
| Type of procedure: | Decentralised | ||||||||||
| Therapeutic Class: | 77 - SYMPATHOLYTICA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 24 | ||||||||||
| Container: | bottle HDPE | ||||||||||
| Route of admin.: | Oral use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 10(1) generic application |
| MA renewed: | Renewal application submitted |
| Pediatric contraindication: | Yes |
| Dokument: |
VHS_súhrn_Dutasterid_tamsulozin Xantis.pdf
|
| Dokument: |
VHS_Dutasterid_tamsulozin Xantis.pdf
|
| SPC: |
SPC_Dutasterid_Tamsulozín FMK_cps dur_08_2023.pdf
|
| PIL: |
PIL_Dutasterid_Tamsulozín FMK_cps dur_08_2023.pdf
|
| Safety feature | Yes |
| Data update: | 03.08.2023 |
